These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. B-type natriuretic peptide as a marker of heart failure: Not so specific after all? Marshall W; Orlando R Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197 [No Abstract] [Full Text] [Related]
26. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)? Arora V; Bhandari S Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049 [No Abstract] [Full Text] [Related]
27. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?]. Zieliński T Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435 [No Abstract] [Full Text] [Related]
28. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome. Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499 [TBL] [Abstract][Full Text] [Related]
29. [Usefulness of NT-ProBNP as a biomarker of clinical status in outpatients with chronic heart failure]. Casado JM; Díaz A; Suárez C Rev Esp Cardiol; 2008 Feb; 61(2):206-10. PubMed ID: 18364191 [TBL] [Abstract][Full Text] [Related]
30. Natriuretic peptides in heart failure: their role in daily practice. Loboz-Grudzień K; Jaroch J Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409 [No Abstract] [Full Text] [Related]
32. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again. Squire I Eur Heart J; 2008 Apr; 29(8):959-60. PubMed ID: 18349028 [No Abstract] [Full Text] [Related]
33. Role of the brain natriuretic peptide in heart failure management. Kalsmith BM Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363 [No Abstract] [Full Text] [Related]
34. The coming of age of natriuretic peptides: the emperor does have clothes! Maisel A J Am Coll Cardiol; 2006 Jan; 47(1):61-4. PubMed ID: 16386665 [No Abstract] [Full Text] [Related]
35. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath]. Bayés-Genís A Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980 [No Abstract] [Full Text] [Related]
36. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
37. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment]. Dahlström U Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945 [No Abstract] [Full Text] [Related]
38. Are multiple biomarker testing strategies ready for prime time in heart failure? Lee DS; Tu JV Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366 [No Abstract] [Full Text] [Related]
39. Diagnosis of heart failure. Chang AM; Maisel AS; Hollander JE Heart Fail Clin; 2009 Jan; 5(1):25-35, vi. PubMed ID: 19026383 [TBL] [Abstract][Full Text] [Related]
40. [Suspected heart failure: how important is the BNP-testing for the general practitioner?]. Pfister R; Erdmann E MMW Fortschr Med; 2009 Apr; 151(15):31-2. PubMed ID: 19728678 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]